Axogen (MEX:AXGN) Growth Rank: 8 (As of Aug. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:AXGN Axogen Inc MEX:AXGN
44 GF Score
Price MXN800.66
GF Value MXN1,610.37
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Axogen Growth Rank?

Axogen MEX:AXGN 44 Growth Rank is 8 as of Aug. 23, 2026. GuruFocus rates MEX:AXGN with a GF Score™ of 44/100 and a GF Value™ of MXN1,610.37 (Significantly Undervalued). The stock has 4 warning signs investors should review.

Axogen has the Growth Rank of 8.

GuruFocus Growth Rank measures the growth of a company in terms of its revenue and profitability, rated on a scale from 1 to 10. Historically, the companies with the highest growth ranks performed the best over the long term. It is calculated using the following criteria:

1. 5-year revenue growth rate, the higher, the better.
2. 3-year revenue growth rate, the higher, the better.
3. 5-year EBITDA growth rate, the higher, the better.
4. The predictability of 5-year revenue. The most consistent it is, the higher the rank.

A higher score reflects a greater ability to drive business growth, with companies considered to have strong and sustainable expansion potential. Conversely, a lower score indicates challenges in achieving consistent growth and scalability.

GuruFocus found that the Growth Rank is the second of the two most-sensitive parameters among the five parameters checked. Please click GF Score to see more details on GF Score's 5 Key Aspects of Analysis.

Please note that we are using the five-year EBITDA growth rate as a parameter, so the company needs to have had positive growth over that time. The reason we use EBITDA instead of earnings per share is that with EBITDA, we can rank a lot more companies since a company may have positive EBITDA but negative EPS. Since we are looking at the growth here, EBITDA gives us a pretty clear picture about the growth in the company's business operations.

MEX:AXGN vs : Growth Rank Comparison

For the Medical Devices subindustry, Axogen's Growth Rank, along with its competitors' market caps and Growth Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Axogen Growth Rank vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Axogen's Growth Rank distribution charts can be found below:

* The bar in red indicates where Axogen's Growth Rank falls into.


MEX:AXGN
44GF Score
Axogen Inc MEX:AXGN
Growth Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Growth Rank →
What does a Growth Rank of 8 mean?
Axogen (MEX:AXGN) has a Growth Rank of 8 as of Aug. 23, 2026. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Axogen and its competitors.
Is Axogen's Growth Rank too high?
Axogen's current Growth Rank is 8. Overall, Axogen has a GF Score™ of 44/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Axogen's Growth Rank compare to ?
Axogen's Growth Rank of 8 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Growth Rank for a Medical Devices & Instruments company?
A good Growth Rank depends on the Medical Devices & Instruments industry context. However, Growth Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Growth Rank mean?
A high Growth Rank can signal that a stock is expensive relative to its fundamentals. Growth Rank measures the growth of a company in terms of its revenue and profitability. View historical data on Axogen and its competitors. Axogen's current Growth Rank is 8. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Axogen stock overvalued right now?
Based on GuruFocus' analysis, Axogen (MEX:AXGN) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,610.37, compared to a current price of MXN800.66 — trading 50.3% below its estimated fair value. The current Growth Rank is 8. Axogen's overall GF Score™ is 44/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Growth Rank calculated?
Growth Rank is calculated from a company's financial statements. For Axogen (MEX:AXGN), the current Growth Rank is 8 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Axogen (MEX:AXGN) Overvalued in 2026?

Based on GuruFocus' analysis, Axogen stock appears to be undervalued. The current stock price of MXN800.66 is trading 50.3% below its estimated GF Value™ of MXN1,610.37. GuruFocus considers Axogen to be Significantly Undervalued.

Key valuation signals for MEX:AXGN:

  • Growth Rank: 8
  • GF Value™: MXN1,610.37 vs. price of MXN800.66 (50.3% below fair value)
  • GF Score™: 44/100 with 4 warning signs

No single metric tells the full story. See the MEX:AXGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Axogen Business Description

Comparable Companies
Other Exchanges AXGN:USA0HKD:UKLT3:Germany
Address 13631 Progress Boulevard, Suite 400, Alachua, FL, USA, 32615
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.
44GF Score

Get the complete analysis for MEX:AXGN

Growth Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN800.66
Price
MXN1,610.37
GF Value